Antimicrobial resistance (AMR) is a global crisis, slower burning than COVID-19 but potentially as catastrophic. It is a growing problem in Aotearoa New Zealand and may cost us dearly: longer hospital stays, poorer outcomes from interventions like surgery and cancer-related care, increased mortality, and elevated healthcare costs.

AMR will disproportionately impact the most socioeconomically disadvantaged amongst us, including Māori and Pacific Peoples, who are more susceptible to infections and have greater reliance on effective antimicrobial therapy.
Check out this bulletin for more information.